KRAS and breast cancer: This included pathways previously linked with breast cancer including Wnt/β-Catenin signaling (false discovery rate, fdr = 0.005), K-Ras (fdr = 0.001), estrogen response (fdr = 0.035), and mitotic spindle (fdr = 0.002) (Fig. 5A,B).